Meet with BioAgilytix at AAPS 2020 PharmSci 360

Don't delay. Register to meet with our scientists today.


Discuss current innovations being made in the pharmaceutical sciences with leading experts from BioAgilytix during AAPS 2020 PharmSci 360. Our attending team of scientists and executives will be discussing evolving industry best practices and how BioAgilytix can help support your complex bioanalytical projects with premium science, service, and quality.

bioanalytical testing

Join BioAgilytix Expert Scientists and Executives Virtually at AAPS PharmSci 360

Jim McNally

Jim McNally, Ph.D.
Chief Scientific Officer

Dr. McNally has an extensive background in bioanalytical assay development and program leadership spanning nearly 20 years working in the pharmaceutical and biotechnology industry.

Roundtable Discussion: Bioanalysis of Gene & Cell Therapies
Friday, October 30, 2020 | 9:00 AM – 10:00 AM EST

Target Selection/Gene Editing Mechanism of Action
Wednesday, November 11, 2020 | 10:45 AM – 11:15 AM EST

Chad Briscoe

Chad Briscoe, Ph.D.
Chief Scientific Officer

As Chief Scientific Officer, Dr. Briscoe provides scientific and regulatory oversight to BioAgilytix’s global teams with strategic guidance in line with emerging scientific developments.

Keynote: Is Your Protein Biomarker Mass Spectrometry Lab Ready For The Next Horizon?
Thursday, October 29, 2020 | 2:00 PM – 3:00 PM EST

Dr. Jennifer Zemo

Dr. Jennifer Zemo

Jennifer has over ten years of post-graduate experience in scientific research and development, including positions at the National Institute of Environmental Health Sciences (NIEHS) and Grifols, Inc.

Assessment of Biotin Interference in Ligand Binding Assays
Late Breaking Poster Abstract

Todd Lester

Todd Lester
Associate Director

Todd Lester has an extensive background in large molecule bioanalysis spanning over 15 years working in CROs and on the pharma side of industry.

Bioanalysis of Biosimilars – Leveraging the past to Shape the Future
Wednesday, November 4, 2020 | 11:30 AM – 12:00 PM EST

Rapid Fire: Bioanalytics – Biomolecular: Are You Ready for the Laboratory of the Future?
Wednesday, November 4, 2020 | 3:30 PM – 4:30 PM EST

comprehensive capabilities

Anita Simkins
VP, Global Quality Assurance

Anita H. Simkins, ASCP, RQAP-GLP is currently the Vice President of Global Quality Assurance at BioAgilytix Labs, L.L.C. Anita has a combination of 30 years of experience working within CLIA, ISO, GMP, GLP and GCP environments within pharmaceutical, diagnostic, biotechnology and Clinical Research Organizations.

Is Your Bioanalytical Lab Ready for a Pandemic?
Tuesday, November 3, 2020 | 3:30 PM – 4:30 PM EST

Luke Armstrong

Luke Armstrong, Ph.D.
Manager II

Luke Armstrong has over 15 years of experience in reagent product development and contract research in cell-based assays, pharmacology, molecular cloning, protein expression, and immunoassays.

Validated Assay for Neutralizing Antibodies Against AAV9 in Human Serum
Wednesday, October 28, 2020 | 9:30 AM – 9:45 AM EST

"In the end, I am most interested in quality results. With BioAgilytix, I know that I am working with veteran scientists capable of solving my toughest problems."

Director of PK/Immunogenicity, Top 5 Pharma

Speak to Our Scientists

Have questions or want to discuss the bioanalytical needs of your gene therapy program in more detail? We’ll set up a time for you to talk to our experts.

Schedule Now


You Don't Want to Miss This

Right before the conference, check out our super cool webinar. We'll be discussing the impact of pre-existing immunogenicity against AAV on gene therapy trials.

Register Now